Loading Events

Hot topics

Event Schedule

Day one

  • 08:30 Joining to the online platform

  • 08:45 Greeting from the Project Lead & GLC Icebreaker Session

  • 08:55 Opening Remarks from the Chair

  • 09:00 Sponsor Speech

  • 09:15 How can RWE support Market Access team(s) in a post COVID landscape

  • 09:45 Can Price Transparency Contribute to More Affordable Patient Access to Medicines?

  • 10:15 Advanced analytics and RWE needs of HTA s/payers for Managed Entry

  • 10:45 Coffee Break

  • 11:00 Market access in Alzheimer’s Disease

  • 11:30 Do Value Based Contract support access to Rare Diseases?

  • 12:00 Speed Date Networking Session

  • 12:20 Lunch Break

  • 13:00 What are the challenges of achieving greater collaboration among payers, HTAs, patients and pharma?

  • 13:30 PANEL DISCUSSION: Philanthropy, social responsibility and drug pricing

  • 14:10 Breath some fresh air

  • 14:30 Same same, but different’: Entering the Rare Disease space – some considerations for a successful launch

  • 15:00 What is the real value of pharmaceutical products in the digital era?

  • 15:30 Closing remarks from the Chair

  • 15:45 End of Day 1

Day two

  • 08:45 Joining to the Online Platform

  • 08:55 Opening Remarks from the Chair

  • 09:00 How the payer is evolving in pricing innovation : value based agreements, indication based pricing and game theory smart deals!

  • 09:30 New pricing and Reimbursement models for advanced therapies

  • 10:00 Round Table Discussion- How to achieve the shift from Volume-based to Value-based Market Access in the EU?

  • 10:30 Let’s grab a coffee

  • 11:00 RWE for orphan Drugs in Germany

  • 11:30 Speaker Q&A

  •  12:00 Reaching a better integration of regulatory pathways

  • 12:30 Lunch Break

  • 13:30 : e-pharma: the revolution to drug market access

  • 14:00 Equal access and multi-indication medicines

  • 14:30 Entering the bio-digital revolution, an age of transformative disruption

  • 15:00 Farewell Networking Session

  • 15:20 Closing remarks from the Chair

  • 15:30 End of Day 2

For detailed program request the agenda

Request detailed Agenda - 6th Pharma Pricing and Reimbursement Forum

Get to know our renowned speakers

Full speaker line-up & more information
Dr. Sebastian Kessel
Dr. Sebastian KesselHead of Market Access & External Engagement Central Europe
Dr. Anne Marciniak
Dr. Anne MarciniakDirector, Strategic Consulting
former Aimmune Therapeutics
United Kingdom
Alexander Bastian
Alexander BastianVice President, Value & Market Access
The Netherlands
Friedrich-Wilhelm Leverkus
Friedrich-Wilhelm LeverkusDirector HTA & Outcomes Research
Jennifer Cain Birkmose
Jennifer Cain BirkmoseVice President, Global Head of Patient Access and Community Engagement Sobi - Swedish Orphan Biovitrum Sweden
Gilles Ducorroy
Gilles DucorroyHead of Real World Evidence
Novartis Global Services
Bernard Hamelin
Bernard HamelinFormer Global Head of Evidence Generation
Katarzyna Kolasa
Katarzyna KolasaProfessor ALK Health Economics, Leader of Health Economics & Big Data Master Program
Kozminski University

Who will you meet?

VPs, Global Head, Heads, Director, Managers OF:

  • Market Access
  • Commercial Pricing
  • Pricing & Reimbursement Strategy
  • Health Economics & Outcomes Research
  • Regulatory Affairs
  • Governmental Affairs
  • Public Affairs
  • Public Policy Operations
  • Payer Insights
  • Real World Evidence
  • Patient Access
  • Corporate Affairs
  • HEOR
  • Medical Affairs International Cooperation
  • Strategic Development Policy & Reimbursement
  • Marketing Business Intelligence
  • Value Insight & Communication
  • Real World Evidence Solutions
  • HTA Strategy
  • HTA Policy
  • Value Access


Interested in more event information?


>>> or see more event details

  • Past event videos
  • Speaker panel
  • Reasons to attend
  • Sponsors
  • Who will you meet
  • Media partners
  • Previous clients
  • Venue and travel information
  • Frequently Asked Questions